56.98
前日終値:
$55.45
開ける:
$56.71
24時間の取引高:
17.78M
Relative Volume:
1.22
時価総額:
$193.17B
収益:
$45.44B
当期純損益:
$16.18B
株価収益率:
15.68
EPS:
3.634
ネットキャッシュフロー:
$9.21B
1週間 パフォーマンス:
+8.72%
1か月 パフォーマンス:
-14.68%
6か月 パフォーマンス:
-35.31%
1年 パフォーマンス:
-58.37%
Novo Nordisk Adr Stock (NVO) Company Profile
NVO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
NVO
Novo Nordisk Adr
|
56.98 | 238.83B | 45.44B | 16.18B | 9.21B | 3.634 |
![]()
LLY
Lilly Eli Co
|
711.68 | 625.77B | 53.26B | 13.80B | -50.20M | 15.30 |
![]()
JNJ
Johnson Johnson
|
179.29 | 424.47B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
210.60 | 364.92B | 58.33B | 3.73B | 18.24B | 2.10 |
![]()
NVS
Novartis Ag Adr
|
126.98 | 240.07B | 53.40B | 13.68B | 16.89B | 6.9231 |
![]()
MRK
Merck Co Inc
|
87.37 | 210.36B | 63.43B | 16.42B | 14.72B | 6.49 |
Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-13 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
2025-08-05 | ダウングレード | UBS | Buy → Neutral |
2025-07-31 | ダウングレード | HSBC Securities | Buy → Hold |
2025-07-30 | ダウングレード | Barclays | Overweight → Equal Weight |
2025-04-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2025-03-13 | アップグレード | Kepler | Hold → Buy |
2025-03-03 | ダウングレード | Stifel | Buy → Hold |
2025-02-12 | 開始されました | Morgan Stanley | Equal-Weight |
2025-01-06 | アップグレード | Bernstein | Underperform → Mkt Perform |
2024-05-30 | 開始されました | Goldman | Buy |
2024-04-12 | 開始されました | BMO Capital Markets | Outperform |
2024-01-23 | 開始されました | Morgan Stanley | Overweight |
2024-01-16 | 再開されました | UBS | Neutral |
2023-12-01 | 開始されました | Cantor Fitzgerald | Overweight |
2023-10-02 | 開始されました | Argus | Buy |
2023-07-14 | 開始されました | HSBC Securities | Buy |
2022-07-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-06-28 | ダウングレード | UBS | Neutral → Sell |
2022-06-27 | アップグレード | Exane BNP Paribas | Underperform → Neutral |
2022-06-07 | アップグレード | JP Morgan | Neutral → Overweight |
2022-05-31 | アップグレード | Guggenheim | Neutral → Buy |
2022-04-25 | アップグレード | Cowen | Market Perform → Outperform |
2022-04-12 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2022-03-16 | アップグレード | Deutsche Bank | Hold → Buy |
2022-01-25 | ダウングレード | Liberum | Hold → Sell |
2021-12-20 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-12-17 | ダウングレード | Deutsche Bank | Buy → Hold |
2021-01-20 | ダウングレード | Credit Suisse | Outperform → Neutral |
2021-01-15 | 開始されました | Deutsche Bank | Buy |
2020-09-29 | 開始されました | Berenberg | Hold |
2020-07-06 | ダウングレード | BofA Securities | Buy → Neutral |
2020-05-11 | ダウングレード | UBS | Buy → Neutral |
2020-05-04 | 開始されました | Cowen | Market Perform |
2020-03-16 | アップグレード | BofA/Merrill | Neutral → Buy |
2020-01-03 | ダウングレード | Guggenheim | Buy → Neutral |
2019-11-18 | アップグレード | Barclays | Equal Weight → Overweight |
2019-09-17 | アップグレード | Citigroup | Neutral → Buy |
2019-08-30 | ダウングレード | Jefferies | Hold → Underperform |
2019-06-20 | ダウングレード | Deutsche Bank | Buy → Hold |
2019-06-11 | アップグレード | Barclays | Underweight → Equal Weight |
2019-04-29 | アップグレード | Credit Suisse | Neutral → Outperform |
2019-01-29 | 開始されました | Exane BNP Paribas | Outperform |
2018-12-11 | 再開されました | Jefferies | Hold |
2018-10-09 | 開始されました | Guggenheim | Buy |
2017-12-29 | アップグレード | JP Morgan | Underweight → Neutral |
2017-12-06 | アップグレード | BofA/Merrill | Neutral → Buy |
2017-12-01 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2017-09-25 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
2017-09-06 | アップグレード | BofA/Merrill | Underperform → Neutral |
すべてを表示
Novo Nordisk Adr (NVO) 最新ニュース
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Using data models to predict Novo Nordisk A s (b Shares) Adrhedged stock movementBuy Signal & Weekly Stock Performance Updates - Newser
Reversal indicators forming on Novo Nordisk A s (b Shares) Adrhedged stockJuly 2025 Action & Daily Growth Stock Investment Tips - Newser
Can momentum traders help lift Novo Nordisk A s (b Shares) Adrhedged2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
Is Novo Nordisk A s (b Shares) Adrhedged showing signs of accumulationJuly 2025 Institutional & Low Risk Entry Point Tips - Newser
Is Novo Nordisk A s (b Shares) Adrhedged still worth holding after the dipTrade Risk Assessment & Consistent Growth Equity Picks - Newser
Does Novo Nordisk A s (b Shares) Adrhedged fit your quant trading modelMarket Trend Summary & Detailed Earnings Play Alerts - Newser
Is Novo Nordisk A s (b Shares) Adrhedged stock ready for a breakoutMarket Risk Report & Verified Short-Term Plans - Newser
What moving averages say about Novo Nordisk A s (b Shares) Adrhedged2025 Top Gainers & Community Verified Swing Trade Signals - Newser
What’s next for Novo Nordisk A s (b Shares) Adrhedged stock priceEarnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
Earnings visualization tools for Novo Nordisk A s (b Shares) AdrhedgedChart Signals & Precise Entry and Exit Recommendations - Newser
Using portfolio simulators with Novo Nordisk A s (b Shares) Adrhedged includedJuly 2025 Catalysts & Verified Momentum Stock Ideas - Newser
Novo Nordisk shares rise 1.58% premarket after board member Christina Law's ADR purchase. - AInvest
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - The Manila Times
Novo Nordisk Board Member Christina Law Buys $0.8 Million in ADRs - AInvest
Novo Nordisk Board Member Christina Law Purchases ADRs Worth DKK 0.8 Million - MarketScreener
Technical signs of recovery in Novo Nordisk A s (b Shares) AdrhedgedPortfolio Risk Report & Real-Time Stock Entry Alerts - Newser
Novo Nordisk A s (b Shares) Adrhedged stock prediction for this weekJuly 2025 Final Week & Pattern Based Trade Signal System - Newser
Glenn Jorgensen @Glennjdk: "𝐖𝐞 𝐡𝐚𝐝 𝐦𝐨𝐫𝐞 𝐍𝐨𝐯𝐨 𝐍𝐨𝐫𝐝𝐢𝐬𝐤..." - eToro
Using data filters to optimize entry into Novo Nordisk A s (b Shares) Adrhedged2025 Top Decliners & Technical Entry and Exit Alerts - Newser
How to monitor Novo Nordisk A s (b Shares) Adrhedged with trend dashboards2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
AI Trend Models Suggest Bounce for Novo Nordisk A s (b Shares) AdrhedgedMarket Weekly Review & AI Driven Price Predictions - Newser
Is Novo Nordisk A s (b Shares) Adrhedged trending in predictive chart modelsWeekly Investment Recap & Fast Gain Stock Trading Tips - Newser
Applying sector rotation models to Novo Nordisk A s (b Shares) AdrhedgedIndex Update & Fast Exit/Entry Strategy Plans - Newser
How to forecast Novo Nordisk A s (b Shares) Adrhedged trends using time seriesMarket Sentiment Report & Long-Term Safe Investment Plans - Newser
Is Novo Nordisk A s (b Shares) Adrhedged Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Chart based exit strategy for Novo Nordisk A s (b Shares) AdrhedgedJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
Full technical analysis of Novo Nordisk A s (b Shares) Adrhedged stockNew Guidance & High Conviction Investment Ideas - Newser
Why Novo Nordisk A s (b Shares) Adrhedged stock attracts strong analyst attentionDollar Strength & Pattern Based Trade Signal System - Newser
Price action breakdown for Novo Nordisk A s (b Shares) AdrhedgedWeekly Trade Recap & Free High Return Stock Watch Alerts - Newser
Novo Nordisk Adr (NVO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):